Opinion

Video

Building An Equitable Future: Strategies for DME Advocacy

Amy Nguyen Howell, MD, MBA, outlines vital initiatives and resources to address health disparities in diabetic macular edema care, emphasizing unconscious bias training, CDC resources, academic courses, and collaborative advocacy efforts for promoting health equity.

This is a video synopsis/summary of an Insights involving Amy Nguyen Howell, MD, MBA.

In response to a question about initiatives and resources for addressing health disparities related to diabetic macular edema (DME), Howell suggests unconscious bias training, citing diversity science and various free courses from platforms like Coursera and universities. She recommends exploring resources on the CDC website, including playbooks and scripts, and highlights valuable materials from the American Academy of Ophthalmology. Howell emphasizes the collective responsibility to advocate for DME patients, addressing challenges like obtaining authorizations early for medications and treatments.

Regarding health equity concerns, Howell stresses the importance of making health equity a reportable metric, linking it to value-based care and payment. She advocates for aligning success metrics with health equity to transform patient treatment and improve health care quality. Howell underscores the need for collaboration, competition, and accountability among stakeholders, including executive leadership, public health organizations, health care entities, innovators, and private companies, to advance health equity, particularly for patients with diabetic macular edema.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.

Related Videos
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
A panel of experts on Alzheimer's disease
A panel of experts on Alzheimer's disease
Neal Shore, MD, FACS, an expert on bladder cancer
Neal Shore, MD, FACS, an expert on bladder cancer
A panel of experts on Alzheimer's disease
A panel of experts on Alzheimer's disease
Related Content
CH LogoCenter for Biosimilars Logo